Annual Report 2025
Bayer Group Consolidated Statements of Cash Flows

€ million

 

Note

 

2024

 

2025

Income after income taxes

 

 

 

(2,546)

 

(3,595)

Income taxes

 

 

 

212

 

466

Financial result

 

 

 

2,263

 

2,052

Income taxes paid

 

 

 

(1,222)

 

(1,243)

Depreciation, amortization and impairment losses (loss reversals)

 

 

 

8,783

 

2,785

Change in pension provisions

 

 

 

(494)

 

(217)

(Gains) losses on retirements of noncurrent assets

 

 

 

(207)

 

(469)

Decrease (increase) in inventories

 

 

 

521

 

475

Decrease (increase) in trade accounts receivable

 

 

 

197

 

(852)

(Decrease) increase in trade accounts payable

 

 

 

(120)

 

(176)

Changes in other working capital, other noncash items

 

 

 

(19)

 

6,704

Net cash provided by (used in) operating activities

 

 

 

7,368

 

5,930

Cash outflows for additions to property, plant, equipment and intangible assets

 

 

 

(2,778)

 

(2,487)

Cash inflows from sales of property, plant, equipment and other assets

 

 

 

295

 

415

Cash inflows from (outflows for) divestments less divested cash

 

 

 

17

 

(2)

Cash inflows from noncurrent financial assets

 

 

 

18

 

144

Cash outflows for noncurrent financial assets

 

 

 

(251)

 

(179)

Cash outflows for acquisitions less acquired cash

 

 

 

(184)

 

(196)

Interest and dividends received

 

 

 

489

 

339

Cash inflows from (outflows for) current financial assets

 

 

 

2,558

 

696

Net cash provided by (used in) investing activities

 

 

 

164

 

(1,270)

Cash outflows to acquire Bayer AG shares (BayShare)

 

 

 

(16)

 

(14)

Dividend payments

 

 

 

(131)

 

(127)

Issuances of debt

 

 

 

5,815

 

6,282

Retirements of debt

 

 

 

(10,833)

 

(8,327)

Interest paid including interest-rate swaps

 

 

 

(1,977)

 

(1,698)

Interest received from interest-rate swaps

 

 

 

5

 

Cash outflows for the purchase of additional interests in subsidiaries

 

 

 

(41)

 

Net cash provided by (used in) financing activities

 

 

 

(7,178)

 

(3,884)

Change in cash and cash equivalents due to business activities

 

[31]

 

354

 

776

Cash and cash equivalents at beginning of year

 

 

 

5,907

 

6,191

Change in cash and cash equivalents due to changes in scope of consolidation

 

 

 

(2)

 

Change in cash and cash equivalents due to hyperinflation of cash flows

 

 

 

(58)

 

(5)

Change in cash and cash equivalents due to exchange rate movements

 

 

 

(10)

 

(291)

Cash and cash equivalents at end of year

 

 

 

6,191

 

6,671